10 completed. 10 Phase 3, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 10 |
| Phase 2 | 5 | Completed 5 |
Follow Hearing Loss: new trials by email Literature Review of Hearing Loss trials Research Report on Hearing Loss
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SPI-1005 for the Treatment of Meniere's Disease Ebselen, Placebo - Meniere Disease, Ménière | Phase 3 | Completed | Sound Pharmaceuticals, Incorporated | 220 | 2022-08-02 | 2026-07-23 |
| Efficacy of SENS 401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss SENS-401, Placebo Oral Tablet - Severe Sudden Sensorineural Hearing Loss | Phase 2 / Phase 3 | Completed | Sensorion | 115 | 2019-02-15 | 2023-03-01 |
| Evaluation of a Binaural Spatialization Method for Hearing Aids Hearing Aids - Sensorineural Hearing Loss | Phase 2 / Phase 3 | Completed | Sonova AG | 40 | 2016-02-01 | 2016-10-04 |
| AM-111 in the Treatment of Acute Inner Ear Hearing Loss Placebo, AM-111 0.4 mg/ml, AM-111 0.8 mg/ml - Hearing Loss | Phase 3 | Completed | Auris Medical AG | 256 | 2015-11-01 | 2023-09-14 |
| Congenital Cytomegalovirus: Efficacy of Antiviral Treatment Valganciclovir - Congenital Cytomegalovirus Infection, Sensorineural Hearing Loss | Phase 3 | Completed | Dr. Ann C.T.M. Vossen | 37 | 2013-10-22 | 2021-06-03 |
| Multicenter Trial Assessing an Innovative VAS of Pain Among Deaf People pictorial VAS, usual VAS - Deafness, Visual Analog Pain Scale | Phase 2 / Phase 3 | Completed | University Hospital, Grenoble | 289 | 2011-06-01 | 2013-07-23 |
| Protective Effect of N-acetylcysteine Against From Ototoxicity N-acetylcysteine - Hearing Loss, Extreme | Phase 2 / Phase 3 | Completed | TC Erciyes University | 60 | 2010-06-01 | 2011-11-16 |
| Chronic Electrical Stimulation of the Auditory Cortex for Intractable Tinnitus significant chronic primary auditory cortex stimulation during the first two weeks, non significant chronic primary auditory cortex stimulation during the first two weeks - Hearing Disorders, Hearing Loss | Phase 2 / Phase 3 | Completed | University Hospital, Bordeaux | 10 | 2007-06-01 | 2011-01-28 |
| Sudden Deafness Treatment Trial prednisone, methylprednisolone sodium succinate - Sudden Deafness | Phase 3 | Completed | Massachusetts Eye and Ear Infirmary | 255 | 2004-12-01 | 2017-04-04 |
| Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss Dexamethasone-dihydrogenphosphate (4mg/ml) - Sudden Deafness | Phase 3 | Completed | University Hospital Tuebingen | 23 | 2003-10-01 | 2008-02-05 |
Deafness (3) · Hearing Loss, Sensorineural (3) · Hearing Loss, Sudden (3) · Hearing Disorders (2) · Tinnitus (2) · Cytomegalovirus Infections (1) · Dizziness (1) · Ear Diseases (1) · Hearing Loss, Unilateral (1) · Hyperacusis (1) · Meniere Disease (1) · Otorhinolaryngologic Diseases (1) · Ototoxicity (1) · Peritonitis (1)
Nervous System Diseases (10) · Neurologic Manifestations (10) · Pathological Conditions, Signs and Symptoms (10) · Ear Diseases (9) · Otorhinolaryngologic Diseases (9) · Sensation Disorders (9) · Signs and Symptoms (9) · Hearing Disorders (8) · Infections (2) · Chemically-Induced Disorders (1) · Communication Disorders (1) · DNA Virus Infections (1) · Digestive System Diseases (1) · Drug-Related Side Effects and Adverse Reactions (1)
Acetylcysteine (1) · D-JNKI-1 (1) · Hearing Aids (1) · Methylprednisolone Hemisuccinate (1) · Prednisone (1) · SENS-401 (1) · Valganciclovir (1) · ebselen (1)
Auris Medical AG (1) · Dr. Ann C.T.M. Vossen (1) · Massachusetts Eye and Ear Infirmary (1) · Sensorion (1) · Sonova AG (1) · Sound Pharmaceuticals, Incorporated (1) · TC Erciyes University (1) · University Hospital Tuebingen (1) · University Hospital, Bordeaux (1) · University Hospital, Grenoble (1)
France (3) · Bulgaria (2) · Germany (2) · Turkey (Türkiye) (2) · United States (2) · Canada (1) · Czechia (1) · Israel (1) · Netherlands (1) · Serbia (1) · Slovakia (1) · Switzerland (1) · United Kingdom (1)
Benoit Mongourdin, PH (1) · Emmanuel Cuny, MD (1) · Gilles Courtois, Enginner (1) · Hans-Peter Zenner, M.D. (1) · Ismail Kocyigit, MD (1) · Stefan K Plontke, M.D. (1) · Steven Rauch, MD (1)
PMID 19172627, PMID 21610239, PMID 22805100, PMID 25017670, PMID 25073872, PMID 29457537, PMID 41026887
U01DC006296 (1)